Ataxia telangiectasia (AT) is a rare neurodegenerative genetic disorder due to bi-allelic mutations in the Ataxia Telangiectasia Mutated (ATM) gene. The aim of this paper is to better define the immunological profile over time, the clinical immune-related manifestations at diagnosis and during follow-up, and to attempt a genotype-phenotype correlation of an Italian cohort of AT patients. Retrospective data of 69 AT patients diagnosed between December 1984 and November 2019 were collected from the database of the Italian Primary Immunodeficiency Network. Patients were classified at diagnosis as lymphopenic (Group A) or non-lymphopenic (Group B). Fifty eight out of 69 AT patients (84%) were genetically characterized and distinguished according to the type of mutations in truncating/truncating (TT; 27 patients), non-truncating (NT)/T (28 patients), and NT/NT (5 patients). In 3 patients, only one mutation was detected. Data on age at onset and at diagnosis, cellular and humoral compartment at diagnosis and follow-up, infectious diseases, signs of immune dysregulation, cancer, and survival were analyzed and compared to the genotype. Lymphopenia at diagnosis was related per se to earlier age at onset. Progressive reduction of cellular compartment occurred during the follow-up with a gradual reduction of T and B cell number. Most patients of Group A carried bi-allelic truncating mutations, had a more severe B cell lymphopenia, and a reduced life expectancy. A trend to higher frequency of interstitial lung disease, immune dysregulation, and malignancy was noted in Group B patients. Lymphopenia at the onset and the T/T genotype are associated with a worst clinical course. Several mechanisms may underlie the premature and progressive immune decline in AT subjects.

Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network / Cirillo, Emilia; Polizzi, Agata; Soresina, Annarosa; Prencipe, Rosaria; Giardino, Giuliana; Cancrini, Caterina; Finocchi, Andrea; Rivalta, Beatrice; Dellepiane, Rosa M; Baselli, Lucia A; Montin, Davide; Trizzino, Antonino; Consolini, Rita; Azzari, Chiara; Ricci, Silvia; Lodi, Lorenzo; Quinti, Isabella; Milito, Cinzia; Leonardi, Lucia; Duse, Marzia; Carrabba, Maria; Fabio, Giovanna; Bertolini, Patrizia; Coccia, Paola; D'Alba, Irene; Pession, Andrea; Conti, Francesca; Zecca, Marco; Lunardi, Claudio; Bianco, Manuela Lo; Presti, Santiago; Sciuto, Laura; Micheli, Roberto; Bruzzese, Dario; Lougaris, Vassilios; Badolato, Raffaele; Plebani, Alessandro; Chessa, Luciana; Pignata, Claudio. - In: JOURNAL OF CLINICAL IMMUNOLOGY. - ISSN 1573-2592. - ELETTRONICO. - 42:(2022), pp. 783-797. [10.1007/s10875-022-01234-4]

Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network

Azzari, Chiara;Ricci, Silvia;Lodi, Lorenzo;Pignata, Claudio
2022

Abstract

Ataxia telangiectasia (AT) is a rare neurodegenerative genetic disorder due to bi-allelic mutations in the Ataxia Telangiectasia Mutated (ATM) gene. The aim of this paper is to better define the immunological profile over time, the clinical immune-related manifestations at diagnosis and during follow-up, and to attempt a genotype-phenotype correlation of an Italian cohort of AT patients. Retrospective data of 69 AT patients diagnosed between December 1984 and November 2019 were collected from the database of the Italian Primary Immunodeficiency Network. Patients were classified at diagnosis as lymphopenic (Group A) or non-lymphopenic (Group B). Fifty eight out of 69 AT patients (84%) were genetically characterized and distinguished according to the type of mutations in truncating/truncating (TT; 27 patients), non-truncating (NT)/T (28 patients), and NT/NT (5 patients). In 3 patients, only one mutation was detected. Data on age at onset and at diagnosis, cellular and humoral compartment at diagnosis and follow-up, infectious diseases, signs of immune dysregulation, cancer, and survival were analyzed and compared to the genotype. Lymphopenia at diagnosis was related per se to earlier age at onset. Progressive reduction of cellular compartment occurred during the follow-up with a gradual reduction of T and B cell number. Most patients of Group A carried bi-allelic truncating mutations, had a more severe B cell lymphopenia, and a reduced life expectancy. A trend to higher frequency of interstitial lung disease, immune dysregulation, and malignancy was noted in Group B patients. Lymphopenia at the onset and the T/T genotype are associated with a worst clinical course. Several mechanisms may underlie the premature and progressive immune decline in AT subjects.
42
783
797
Cirillo, Emilia; Polizzi, Agata; Soresina, Annarosa; Prencipe, Rosaria; Giardino, Giuliana; Cancrini, Caterina; Finocchi, Andrea; Rivalta, Beatrice; Dellepiane, Rosa M; Baselli, Lucia A; Montin, Davide; Trizzino, Antonino; Consolini, Rita; Azzari, Chiara; Ricci, Silvia; Lodi, Lorenzo; Quinti, Isabella; Milito, Cinzia; Leonardi, Lucia; Duse, Marzia; Carrabba, Maria; Fabio, Giovanna; Bertolini, Patrizia; Coccia, Paola; D'Alba, Irene; Pession, Andrea; Conti, Francesca; Zecca, Marco; Lunardi, Claudio; Bianco, Manuela Lo; Presti, Santiago; Sciuto, Laura; Micheli, Roberto; Bruzzese, Dario; Lougaris, Vassilios; Badolato, Raffaele; Plebani, Alessandro; Chessa, Luciana; Pignata, Claudio
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/1287329
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact